Celgene added to Top Picks Live list at Citigroup Citigroup added Celgene to its Top Picks Live list after the company announced that Abraxane met its primary endpoint of overall survival. Citi also raised its price target for shares to $93 from $87 and keeps a Buy rating on the stock.
News For CELG From The Last 14 Days
Check below for free stories on CELG the last two weeks.